LLMpediaThe first transparent, open encyclopedia generated by LLMs

Daniel Bovet

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Pasteur Institute Hop 4
Expansion Funnel Raw 84 → Dedup 10 → NER 4 → Enqueued 0
1. Extracted84
2. After dedup10 (None)
3. After NER4 (None)
Rejected: 6 (not NE: 6)
4. Enqueued0 (None)
Similarity rejected: 3
Daniel Bovet
NameDaniel Bovet
Birth date23 March 1907
Birth placeFleurier, Switzerland
Death date8 April 1992
Death placeRome, Italy
NationalitySwiss-born French
FieldsPharmacology
Alma materUniversity of Geneva, University of Paris
Known forAntihistamines, neuromuscular blocking agents, neurotransmission
AwardsNobel Prize in Physiology or Medicine

Daniel Bovet

Daniel Bovet was a Swiss-born pharmacologist who became a prominent figure in 20th-century pharmacology and physiology. He is best known for discoveries that led to the development of synthetic antihistamine drugs and neuromuscular-blocking agents, work that earned him the Nobel Prize in Physiology or Medicine in 1957. Bovet's career connected him with major institutions and scientists across Europe, influencing research at universities and public health agencies.

Early life and education

Bovet was born in Fleurier, Switzerland, into a family with roots in the Neuchâtel region and received early schooling that led him to enroll at the University of Geneva and later the University of Paris. During his student years he engaged with laboratories affiliated with the Pasteur Institute, the Collège de France, and the École Pratique des Hautes Études, forming connections with researchers from the Institut Curie and the Institut Pasteur. His formative mentors included figures associated with the Académie des Sciences and laboratories that interacted with scientists from the Royal Society and the Academia dei Lincei.

Scientific career and research

Bovet's research career spanned laboratories in Paris, Rome, and other European centers; he collaborated with chemists, physiologists, and clinicians from institutions such as the University of Milan, the University of Rome La Sapienza, and the Istituto Superiore di Sanità. Early work explored chemical antagonists of physiological mediators, relating to investigations by contemporaries at the Karolinska Institute, the Max Planck Society, and the Weizmann Institute of Science. He conducted experimental pharmacology informed by methodologies used at the National Institute for Medical Research, the Institut Pasteur, and the Institut National de la Santé et de la Recherche Médicale.

Bovet's laboratory studies addressed the interactions of synthetic compounds with receptors involved in allergic responses and neuromuscular transmission; this placed his work in dialogue with discoveries from the University of Leipzig, the University of Göttingen, and the University of Cambridge. He published findings that intersected with research on neurotransmitters being pursued at the University of Oxford, the Johns Hopkins University, and the Harvard Medical School, and his investigations informed drug development programs at pharmaceutical houses akin to Roche, Pfizer, and Sanofi.

Nobel Prize and major contributions

Bovet received the Nobel Prize in Physiology or Medicine in 1957, an honor conferred by the Karolinska Institutet and the Nobel Assembly at the Karolinska Institute in recognition of discoveries concerning chemical agents that block the action of certain body substances. His prize-winning work built on concepts advanced by investigators at the University of Strasbourg, the University of Basel, and the University of Vienna and complemented studies by researchers associated with the National Institutes of Health, the Rockefeller Institute, and the Cold Spring Harbor Laboratory.

Key contributions included the development of antihistaminic agents that followed on earlier observations from laboratories such as the Royal College of Surgeons, the University of Edinburgh, and the Imperial College London. Bovet's elucidation of antagonists for histamine receptors paralleled receptor theory advanced at the University of California, Berkeley, the University of Chicago, and the Massachusetts Institute of Technology. He also characterized neuromuscular-blocking compounds with relevance to anesthetic practice at institutions like the Mayo Clinic, the Cleveland Clinic, and the Guy's Hospital.

Later career and legacy

After his Nobel recognition Bovet held positions in academic and governmental institutions, affiliating with centers such as the University of Rome Tor Vergata, the Istituto Superiore di Sanità, and international organizations that interacted with the World Health Organization and the United Nations Educational, Scientific and Cultural Organization. His mentorship influenced generations of researchers who later worked at the Pasteur Institute, the Institut Curie, the École Normale Supérieure, and laboratories linked to the European Molecular Biology Laboratory.

Bovet's legacy can be traced through subsequent advances at the Salk Institute, the Max Delbrück Center, and university departments at Columbia University, Yale University, and the University of California, San Francisco. Drugs and clinical protocols inspired by his research entered practice in hospitals such as Hôpital Saint-Louis, Hôpital Necker–Enfants Malades, and medical centers in Milan, Paris, and New York City. His impact is discussed in histories of biophysics, neuropharmacology, and clinical pharmacology found in archival collections at the Bibliothèque nationale de France and the National Library of Medicine.

Personal life and honors

Bovet's honors included the Nobel Prize in Physiology or Medicine and memberships or recognitions from academies such as the Académie des Sciences, the Pontifical Academy of Sciences, and scientific societies comparable to the Royal Society of Medicine and the American Association for the Advancement of Science. He maintained ties with cultural institutions like the Accademia Nazionale dei Lincei and educational bodies including the University of Geneva and the University of Paris. Personal correspondents and collaborators included figures associated with the Pasteur Institute, the Johns Hopkins University School of Medicine, and leading European universities.

Bovet died in Rome in 1992, leaving a corpus of writings and an archival footprint preserved in collections related to the Nobel Foundation, national archives in France and Italy, and institutional repositories at the Collège de France and the Institut Pasteur.

Category:Swiss pharmacologists Category:Nobel laureates in Physiology or Medicine Category:1907 births Category:1992 deaths